Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CISH | CTRPv2 | pan-cancer | AAC | 0.46 | 3e-38 |
mRNA | TRH | GDSC1000 | pan-cancer | AAC | 0.35 | 7e-27 |
mRNA | PIM1 | CTRPv2 | pan-cancer | AAC | 0.38 | 9e-26 |
mRNA | PRSS57 | CTRPv2 | pan-cancer | AAC | 0.37 | 6e-25 |
mRNA | VSIG4 | GDSC1000 | pan-cancer | AAC | 0.3 | 1e-19 |
mRNA | PDGFRA | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-19 |
mRNA | RP11-231C18.3 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-18 |
mRNA | PRSS57 | GDSC1000 | pan-cancer | AAC | 0.31 | 4e-17 |
mRNA | CSF1R | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-16 |
mRNA | DCUN1D4 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-14 |